Bibora Labs achieves 294% rapid growth in just one year of exports... Differentiating through technology transfers

Bibora Labs, a domestic cosmetics manufacturer and distributor, is recording steep growth in overseas export markets. Since beginning full-scale overseas expansion in 2024, the company achieved a result where the export scale surged approximately 294% in the year 2025 compared to the second half of the previous year.

According to a KOTRA TV video, Bibora Labs began discovering buyers in Mexico in 2024 and pioneered markets in Central and South America, including Colombia, and in 2025, focused on market expansion by traveling around the world. In particular, in the first half of 2026, they are also producing results in European markets such as Italy and Madrid, Spain.

"KOTRA's trade offices in each country are truly great weapons for us"

Bibora Labs cited KOTRA's support system as the core driving force that allowed the small and medium-sized enterprise to settle in overseas markets. In the video, it was explained that KOTRA's trade offices in each country are a great weapon by resolving language barriers and helping to form relationships with local buyers. Additionally, it was stated that buyer matching through the AI Center and support for video conferences served as decisive opportunities leading to sales.

Bibora Labs is continuously discovering buyers in global markets such as Europe through KOTRA's 'Buy Korea' platform, and is overcoming the limitations of information and language that a small and medium-sized enterprise may experience through close cooperation with local trade offices.

"By entering into technology transfer contracts for the good technologies of Gyeongsangbuk-do Provincial Government or research institutes"

A product differentiation strategy based on technological prowess lies at the background of Bibora Labs' growth. To supplement the limitations of its own R&D, the company is utilizing 'technology transfer contracts' to introduce excellent technologies from public institutions such as the Gyeongsangbuk-do Provincial Government and research institutes as a core strategy. Through this, the patented ingredients and research data secured are being directly applied to product development.

The flagship product, 'Bibora Geneon Line', applies patented technology that ferments RG3, an ingredient derived from ginseng. In particular, the sunscreen product, which is currently recording the number one export, is drawing high responses from overseas consumers by highlighting that it has no white cast, minimal eye stinging or stickiness, and has completed hypoallergenic testing. Furthermore, the company is expanding its product portfolio through new products using gold thread and vitamin capsules, as well as a mask pack lineup subdivided by function, such as anti-aging/regeneration lines and whitening lines.